A Phase III, Placebo-Controlled, Double-Blind, Randomized Trial Assessing the Effect of Tramiprosate on Hippocampus Volume Change in Patients with Mild-to-Moderate Alzheimer's Disease (The Alphase Study)

被引：0
|
作者：
Gauthier, Serge
Aisen, Paul
Ferris, Steven
Garceau, Denis
Saumier, Daniel
Duong, Anh
Sampalis, John
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A246 / A247
页数：2
相关论文
共 50 条
  • [31] Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
    Bruno Dubois
    Jesús López-Arrieta
    Stanley Lipschitz
    Triantafyllos Doskas
    Luiza Spiru
    Svitlana Moroz
    Olena Venger
    Patrick Vermersch
    Alain Moussy
    Colin D. Mansfield
    Olivier Hermine
    Magda Tsolaki
    Alzheimer's Research & Therapy, 15
  • [32] A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer's disease
    Brody, Mark
    Liu, Enchi
    Di, Jianing
    Lu, Ming
    Margolin, Richard A.
    Werth, John L.
    Booth, Kevin
    Shadman, Anna
    Brashear, H. Robert
    Novak, Gerald
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (04) : 1509 - 1519
  • [33] Estrogen for Alzheimer's disease in women - Randomized, double-blind, placebo-controlled trial
    Henderson, VW
    Paganini-Hill, A
    Miller, BL
    Elble, RJ
    Reyes, PF
    Shoupe, D
    McCleary, CA
    Klein, RA
    Hake, AM
    Farlow, MR
    NEUROLOGY, 2000, 54 (02) : 295 - 301
  • [34] Optimal Dosing of Galantamine in Patients with Mild or Moderate Alzheimer’s DiseasePost Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial
    Stephen Aronson
    Bart Van Baelen
    Shane Kavanagh
    Susanne Schwalen
    Drugs & Aging, 2009, 26 : 231 - 239
  • [35] Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial
    Gold, Linda Stein
    Papp, Kim
    Pariser, David
    Green, Lawrence
    Bhatia, Neal
    Sofen, Howard
    Albrecht, Lorne
    Gooderham, Melinda
    Chen, Mindy
    Paris, Maria
    Wang, Yao
    Duffin, Kristina Callis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) : 77 - 85
  • [36] Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
    Doody, Rachelle S.
    Gavrilova, Svetlana I.
    Sano, Mary
    Thomas, Ronald G.
    Aisen, Paul S.
    Bachurin, Sergey O.
    Seely, Lynn
    Hung, David
    LANCET, 2008, 372 (9634): : 207 - 215
  • [37] A 36-week multicenter, randomized, double-blind, placebo-controlled,parallel-group, Phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer disease
    XIAO Shi-fu
    中国药理学与毒理学杂志, 2019, 33 (06) : 403 - 403
  • [38] A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease
    Sano, M.
    Bell, K. L.
    Galasko, D.
    Galvin, J. E.
    Thomas, R. G.
    van Dyck, C. H.
    Aisen, P. S.
    NEUROLOGY, 2011, 77 (06) : 556 - 563
  • [39] Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus - A multicenter randomized, double-blind, placebo-controlled trial
    Chang, DM
    Lan, JL
    Lin, HY
    Luo, SF
    ARTHRITIS AND RHEUMATISM, 2002, 46 (11): : 2924 - 2927
  • [40] Crocus sativus L. (petal) in the treatment of mild-to-moderate depression:: A double-blind, randomized and placebo-controlled trial
    Moshiri, Esmail
    Basti, Afshin Akhondzadeh
    Noorbala, Ahamad-Ali
    Jamshidi, Amir-Hossein
    Abbasi, Seyed Hesameddin
    Akhondzadeh, Shahin
    PHYTOMEDICINE, 2006, 13 (9-10) : 607 - 611
12345